HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Antonio Giovanni Solimando Selected Research
Antonio Giovanni Solimando Research Topics
Disease
27
Neoplasms (Cancer)
04/2024 - 08/2013
18
Multiple Myeloma
04/2024 - 01/2012
9
COVID-19
01/2024 - 01/2020
8
Monoclonal Gammopathy of Undetermined Significance
04/2024 - 11/2014
5
Hepatocellular Carcinoma (Hepatoma)
02/2023 - 10/2019
3
Infections
01/2024 - 06/2021
3
Neoplasm Metastasis (Metastasis)
12/2023 - 01/2020
3
Inflammation (Inflammations)
10/2023 - 01/2021
3
Renal Cell Carcinoma (Grawitz Tumor)
03/2023 - 03/2020
3
Disease Progression
07/2021 - 04/2020
2
Carcinoma (Carcinomatosis)
12/2023 - 11/2021
2
Virus Diseases (Viral Diseases)
02/2022 - 08/2021
2
Prostatic Neoplasms (Prostate Cancer)
01/2022 - 03/2020
2
Colorectal Neoplasms (Colorectal Cancer)
05/2021 - 12/2019
2
Pancreatic Neoplasms (Pancreatic Cancer)
04/2021 - 03/2019
2
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2018 - 03/2016
2
Lymphoma (Lymphomas)
01/2018 - 03/2016
1
Hypercholesterolemia
01/2024
1
Hypertension (High Blood Pressure)
10/2023
1
Vasculitis (Vasculitides)
10/2023
1
Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
10/2023
1
Thrombosis (Thrombus)
03/2023
1
Atrial Fibrillation
03/2023
1
Liver Diseases (Liver Disease)
02/2023
1
Respiratory Insufficiency (Respiratory Failure)
02/2023
1
Pneumonia (Pneumonitis)
02/2023
1
Autosomal Dominant Rhegmatogenous Retinal Detachment
12/2022
1
Hematologic Neoplasms (Hematological Malignancy)
09/2022
1
Carcinogenesis
07/2021
1
Adrenal Insufficiency (Adrenal Gland Hypofunction)
06/2021
1
Endocrine System Diseases (Endocrine Diseases)
06/2021
1
Osteoporosis
06/2021
1
Abscess
05/2021
1
Triple Negative Breast Neoplasms
01/2021
1
Heart Failure
01/2021
1
Takotsubo Cardiomyopathy
01/2021
1
Amyloidosis
10/2020
1
Circulating Neoplastic Cells
05/2020
Drug/Important Bio-Agent (IBA)
8
Biomarkers (Surrogate Marker)
IBA
01/2024 - 11/2019
7
MicroRNAs (MicroRNA)
IBA
03/2023 - 11/2019
6
Proteins (Proteins, Gene)
FDA Link
04/2024 - 11/2014
5
Immune Checkpoint Inhibitors
IBA
12/2023 - 10/2019
4
Bortezomib (Velcade)
FDA Link
02/2020 - 08/2013
2
Proteasome Endopeptidase Complex (Proteasome)
IBA
04/2024 - 02/2020
2
Tumor Biomarkers (Tumor Markers)
IBA
02/2023 - 05/2020
2
Oxygen (Dioxygen)
IBA
01/2023 - 07/2020
2
RNA (Ribonucleic Acid)
IBA
01/2023 - 11/2014
2
Sorafenib (BAY 43-9006)
FDA Link
02/2022 - 10/2019
2
Angiogenesis Inhibitors
IBA
01/2022 - 02/2020
2
Cytokines
IBA
08/2021 - 05/2021
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
07/2021 - 03/2018
2
Immune Checkpoint Proteins
IBA
05/2021 - 04/2021
2
Tyrosine Kinase Inhibitors
IBA
03/2020 - 11/2014
2
Neutralizing Antibodies
IBA
01/2020 - 11/2014
2
((3Z)- N- (3- chlorophenyl)- 3- ((3,5- dimethyl- 4- ((4- methylpiperazin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- N- methyl- 2- oxo- 2,3- dihydro- 1H- indole- 5- sulfonamide)
IBA
11/2014 - 08/2013
1
Messenger RNA (mRNA)
IBA
04/2024
1
Interleukin-6 (Interleukin 6)
IBA
01/2024
1
Cisplatin (Platino)
FDA Link
Generic
12/2023
1
Glucocorticoids
IBA
10/2023
1
Antineutrophil Cytoplasmic Antibodies (ANCA)
IBA
10/2023
1
Lipids
IBA
10/2023
1
tofacitinib
IBA
02/2023
1
Immunomodulating Agents
IBA
02/2023
1
bamlanivimab and etesevimab drug combination
IBA
01/2023
1
Proliferating Cell Nuclear Antigen (PCNA)
IBA
01/2023
1
Peroxisome Proliferator-Activated Receptors (PPAR)
IBA
01/2023
1
Angiotensins
IBA
01/2023
1
Melphalan (Alkeran)
FDA Link
Generic
12/2022
1
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
02/2022
1
Vitamin D
FDA Link
Generic
01/2022
1
Antigens
IBA
01/2022
1
Interleukin-17 (Interleukin 17)
IBA
08/2021
1
Interferon Type I
IBA
08/2021
1
lime (calcium oxide)
FDA Link
08/2021
1
Vaccines
IBA
08/2021
1
Phosphorus (Red Phosphorus)
IBA
06/2021
1
Calcium
IBA
06/2021
1
Hydrocortisone (Cortisol)
FDA Link
Generic
06/2021
1
CTLA-4 Antigen
IBA
05/2021
1
Mucins
IBA
05/2021
1
Capecitabine (Xeloda)
FDA Link
05/2021
1
Anti-Bacterial Agents (Antibiotics)
IBA
05/2021
1
Autoantigens
IBA
01/2021
1
B7-H1 Antigen
IBA
01/2021
1
omega-Chloroacetophenone (Mace)
IBA
01/2021
1
DNA (Deoxyribonucleic Acid)
IBA
01/2021
1
Programmed Cell Death 1 Receptor
IBA
01/2021
1
Immunoglobulins (Immunoglobulin)
IBA
10/2020
Therapy/Procedure
19
Therapeutics
02/2023 - 01/2012
4
Immunotherapy
12/2023 - 01/2019
3
Critical Care (Surgical Intensive Care)
01/2024 - 01/2020
3
Drug Therapy (Chemotherapy)
12/2023 - 03/2016
2
Precision Medicine
09/2022 - 07/2019
1
Radiotherapy
12/2023
1
Artificial Respiration (Mechanical Ventilation)
02/2023
1
Castration
01/2022
1
Immunomodulation
11/2021
1
Oral Surgery (Maxillofacial Surgery)
05/2021
1
Endodontics
05/2021
1
Renal Dialysis (Hemodialysis)
10/2020